FNB in Meniscal Tear Under SA
Launched by CHUNCHEON SACRED HEART HOSPITAL · Sep 19, 2023
Trial Information
Current as of July 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a method called a femoral nerve block, which is a way to manage pain during arthroscopic surgery for a meniscus tear in the knee. The researchers want to find out how effective this nerve block is when combined with spinal anesthesia, which is a type of anesthesia that numbs the body from the waist down. The goal is to improve pain control and recovery for patients undergoing this common knee surgery.
To be eligible for the trial, participants need to be scheduled for meniscal surgery and must understand the study well enough to give their consent to join. However, individuals with certain conditions, like additional knee injuries or those who have had previous knee surgeries, cannot participate. If you join the study, you can expect to receive detailed information about the procedure and its potential benefits and risks. It's important to note that this trial is currently not recruiting participants, so it may not be possible to join just yet.
Gender
ALL
Eligibility criteria
- Inclsuion Criteria:
- • individuals who are scheduled to undergo meniscal surgery and must be received sufficient explanation about the research prior to surgery and have provided their informed consent to participate.
- Exclusion Criteria:
- • who require simultaneous surgery for concomitant cartilage injury, collateral ligament tear.
- • who have previously undergone surgical treatment within the knee joint.
- • who have declined to participate in the research.
- • where medical, surgical, or anesthetic complications occurred during surgery.
- • other cases deemed necessary by the researchers.
About Chuncheon Sacred Heart Hospital
Chuncheon Sacred Heart Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Located in Chuncheon, South Korea, the hospital is committed to delivering high-quality care while fostering a collaborative environment for researchers and healthcare professionals. With a focus on various therapeutic areas, Chuncheon Sacred Heart Hospital leverages its state-of-the-art facilities and experienced clinical teams to conduct rigorous trials that adhere to the highest ethical standards. The institution aims to enhance medical knowledge and contribute to the development of new treatments that address unmet patient needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chuncheon, Gangwon Do, Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported